SI1355906T1 - 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof - Google Patents

2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Info

Publication number
SI1355906T1
SI1355906T1 SI200230096T SI200230096T SI1355906T1 SI 1355906 T1 SI1355906 T1 SI 1355906T1 SI 200230096 T SI200230096 T SI 200230096T SI 200230096 T SI200230096 T SI 200230096T SI 1355906 T1 SI1355906 T1 SI 1355906T1
Authority
SI
Slovenia
Prior art keywords
preparation
processes
pharmaceutical compositions
benzopyran derivatives
benzopyran
Prior art date
Application number
SI200230096T
Other languages
English (en)
Slovenian (sl)
Inventor
Maurizio Delcanale
Gabriele Amari
Elisabetta Armani
Maurizio Civelli
Elisabetta Galbiati
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01101521A external-priority patent/EP1229036B1/en
Priority claimed from EP01118682A external-priority patent/EP1281710A1/en
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of SI1355906T1 publication Critical patent/SI1355906T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
SI200230096T 2001-01-24 2002-01-21 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof SI1355906T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01101521A EP1229036B1 (en) 2001-01-24 2001-01-24 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
EP01118682A EP1281710A1 (en) 2001-08-03 2001-08-03 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
EP02703564A EP1355906B1 (en) 2001-01-24 2002-01-21 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
PCT/EP2002/000567 WO2002059113A1 (en) 2001-01-24 2002-01-21 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
SI1355906T1 true SI1355906T1 (en) 2005-06-30

Family

ID=26076450

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230096T SI1355906T1 (en) 2001-01-24 2002-01-21 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Country Status (27)

Country Link
US (1) US6951883B2 (ru)
EP (1) EP1355906B1 (ru)
JP (1) JP4332349B2 (ru)
CN (1) CN1261431C (ru)
AT (1) ATE286894T1 (ru)
AU (1) AU2002237282B2 (ru)
BR (1) BR0207066A (ru)
CA (1) CA2435775A1 (ru)
CZ (1) CZ20032014A3 (ru)
DE (1) DE60202590T2 (ru)
DK (1) DK1355906T3 (ru)
DZ (1) DZ3459A1 (ru)
EA (1) EA006158B1 (ru)
ES (1) ES2236485T3 (ru)
HK (1) HK1060558A1 (ru)
HU (1) HUP0401018A3 (ru)
IL (2) IL157065A0 (ru)
MA (1) MA26982A1 (ru)
MX (1) MXPA03006505A (ru)
NO (1) NO327808B1 (ru)
NZ (1) NZ527144A (ru)
PL (1) PL365062A1 (ru)
PT (1) PT1355906E (ru)
SI (1) SI1355906T1 (ru)
SK (1) SK287086B6 (ru)
TN (1) TNSN03043A1 (ru)
WO (1) WO2002059113A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CN101056868B (zh) 2004-09-21 2012-05-02 马休爱德华兹股份有限公司 取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用
ES2377073T3 (es) * 2004-09-21 2012-03-22 Marshall Edwards, Inc. Derivados de cromano sustituidos, medicamentos y utilización en terapia
WO2006032086A1 (en) * 2004-09-21 2006-03-30 Novogen Research Pty Ltd Chroman derivatives, medicaments and use in therapy
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ,インク. 化合物
AU2005201855B2 (en) * 2004-09-21 2012-03-29 Marshall Edwards, Inc. Chroman derived compounds and formulations thereof for use in therapy
CN101444499B (zh) * 2007-11-26 2012-12-05 湘北威尔曼制药股份有限公司 一种化合物及其组合物的新用途
CA2816319C (en) 2010-11-01 2020-06-30 Marshall Edwards, Inc. Isoflavonoid compounds and methods for the treatment of cancer
EP3010501B1 (en) 2013-06-19 2021-11-03 Seragon Pharmaceuticals, Inc. Estrogen receptor modulator and uses thereof
HUE054998T2 (hu) 2015-02-02 2021-10-28 Mei Pharma Inc Kombinációs terápiák emlõrák kezelésében való alkalmazásra
JP6946430B2 (ja) * 2016-11-17 2021-10-06 サノフイSanofi 新規の置換n−(3−フルオロプロピル)−ピロリジン化合物、それを製造するための方法、およびその治療的使用
US20200215025A1 (en) * 2017-09-15 2020-07-09 Norbio No. 1 Pty Ltd Treatment of excitotoxicity
CN112225716A (zh) * 2020-10-30 2021-01-15 陕西嘉禾生物科技股份有限公司 一种鹰嘴豆牙素a的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374245A (en) * 1964-04-01 1968-03-19 Ciba Geigy Corp Unsaturated oxacycles
DE1518002C3 (de) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
WO1998018774A1 (en) 1996-10-28 1998-05-07 Novo Nordisk A/S Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
EP0944613B1 (en) * 1996-12-13 2002-10-09 Chugai Seiyaku Kabushiki Kaisha Benzopyran derivatives
KR20000001793A (ko) 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
JP2002533456A (ja) 1998-12-30 2002-10-08 シグナル ファーマシューティカルズ, インコーポレイテッド エストロゲン受容体のモジュレートを行うための化合物および方法

Also Published As

Publication number Publication date
JP2004517151A (ja) 2004-06-10
EP1355906A1 (en) 2003-10-29
SK287086B6 (sk) 2009-11-05
DE60202590D1 (de) 2005-02-17
MXPA03006505A (es) 2004-04-21
MA26982A1 (fr) 2004-12-20
NO327808B1 (no) 2009-09-28
DK1355906T3 (da) 2005-05-30
NO20033318D0 (no) 2003-07-23
JP4332349B2 (ja) 2009-09-16
HUP0401018A2 (hu) 2004-09-28
BR0207066A (pt) 2004-03-30
IL157065A0 (en) 2004-02-08
US20040106595A1 (en) 2004-06-03
SK9392003A3 (en) 2003-12-02
EP1355906B1 (en) 2005-01-12
NZ527144A (en) 2005-03-24
EA006158B1 (ru) 2005-10-27
US6951883B2 (en) 2005-10-04
WO2002059113A1 (en) 2002-08-01
HUP0401018A3 (en) 2007-05-29
ES2236485T3 (es) 2005-07-16
CZ20032014A3 (cs) 2003-12-17
CN1487934A (zh) 2004-04-07
ATE286894T1 (de) 2005-01-15
TNSN03043A1 (en) 2005-12-23
CA2435775A1 (en) 2002-08-01
NO20033318L (no) 2003-09-24
PT1355906E (pt) 2005-05-31
DZ3459A1 (fr) 2002-08-01
IL157065A (en) 2010-05-17
AU2002237282B2 (en) 2007-02-15
PL365062A1 (en) 2004-12-27
DE60202590T2 (de) 2005-12-29
CN1261431C (zh) 2006-06-28
HK1060558A1 (en) 2004-08-13
EA200300727A1 (ru) 2004-02-26

Similar Documents

Publication Publication Date Title
IL158784A (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, processes for their preparation and pharmaceutical compositions containing them
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HUP0303148A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
IL161857A0 (en) Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
HUP0401718A3 (en) Bicyclic oxopyridine and oxopyrimidine derivatives, their use and pharmaceutical compositions containing them
PL367682A1 (en) Dolastatin 10 derivatives
IL158898A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
HUP0500024A3 (en) 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
HUP0402028A3 (en) Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
AP2001002369A0 (en) Pharmaceutical complex.
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
HUP0400154A3 (en) Heterocondesated benzoxazepine and benzoxathiazepine derivatives, their use and pharmaceutical compositions containing them
SI1245565T1 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
HUP0303238A3 (en) Hiv inhibiting n-aminoimidazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them
HUP0402283A3 (en) Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
CA2420056A1 (en) 1-amino-alkylcyclohexanes as trypanocidal agents
ZA200110073B (en) 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments.
SI1275641T1 (en) Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0401446A3 (en) Heterocondensated indole and heteroindole derivatives, the production and use thereof and pharmaceutical compositions containing them